Physician profile
Vasantha Samala
NPI 1053430033
$2,758.06
in general payments reported to CMS, 2019-2025
28 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $166 · 2022: $112 · 2023: $456 · 2024: $466 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $594.55 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.72 | 2019-2023 | Ofev |
| Astrazeneca Pharmaceuticals LP | $311.32 | 2019-2025 | Airsupra |
| Grifols USA, LLC | $235.18 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $200.67 | 2023-2025 | |
| Genentech USA, INC. | $152.60 | 2019-2020 | |
| Philips North America LLC | $135.90 | 2019-2024 | (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $105.63 | 2019-2025 | Keytruda, Zerbaxa, Recarbrio |
| Mylan Specialty L.P. | $87.63 | 2019-2024 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $85.55 | 2019 | |
| Baxter Healthcare | $54.01 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Avadel Cns Pharmaceuticals, LLC | $52.69 | 2024 | Lumryz |
| Ceribell, INC. | $49.14 | 2024 | Pocket Eeg Device |
| Vifor Pharma, INC. | $35.00 | 2024 | Zemaira |
| Insmed, INC. | $34.89 | 2025 | Arikayce |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $30.42 | 2023 | Wakix |
| Inspire Medical Systems, INC. | $25.74 | 2025 | Inspire |
| Lilly USA, LLC | $23.50 | 2025 | |
| Tactile Systems Technology INC | $22.12 | 2023 | Flexitouch Plus, Entre Plus |
| Shionogi INC | $20.77 | 2024 | Fetroja |
| Genzyme Corporation | $20.04 | 2023 | |
| La Jolla Pharmaceutical Company | $19.90 | 2023 | Giapreza |
| Breathe Technologies, INC. | $18.86 | 2019 | |
| Viatris Specialty LLC | $18.86 | 2025 | Yupelri |
| Inogen, INC. | $18.71 | 2024 | |
| Pulmonx Corporation | $17.87 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $17.20 | 2025 | Glassia |
| Shire North American Group INC | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasantha Samala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.